Matthew Sexton, MD | |
911 Bypass Rd Bldg A, Pikeville, KY 41501-1602 | |
(606) 430-3500 | |
(606) 437-1033 |
Full Name | Matthew Sexton |
---|---|
Gender | Male |
Speciality | Critical Care (intensivists) |
Experience | 10 Years |
Location | 911 Bypass Rd Bldg A, Pikeville, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013326149 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 59564 (Minnesota) | Secondary |
207LC0200X | Anesthesiology - Critical Care Medicine | 58512 (Kentucky) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Pikeville Medical Center | Pikeville, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pikeville Medical Center Inc | 6709790157 | 314 |
News Archive
Many cancer patients struggle with the adverse effects of chemotherapy, still the most prescribed cancer treatment. For patients with pancreatic cancer and other aggressive cancers, the forecast is more grim: there is no known effective therapy.
Almost every day brings news of an apparent breakthrough against cancer, infectious diseases, or metabolic conditions like diabetes, but these rarely translate into effective therapies or drugs, and even if they do clinical development usually takes well over a decade.
A common virus that can cause coughing and mild diarrhea appears to have a major redemptive quality: the ability to kill cancer. Harnessing that power, researchers at Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, are conducting a clinical trial to see if the virus can target and kill certain tumor types.
Viragen, Inc. today announced that the Company extended its agreement with the University of Miami and UM/Sylvester Comprehensive Cancer Center to develop a novel form of an immune enhancing drug (IEP 11) that has shown promise in animal studies by inhibiting tumor growth in a broad range of cancers.
Cell phones are accumulating a Swiss Army Knife-esqe assortment of capabilities; substituting as cameras, providing internet access, and soon operating as medical labs if Aydogan Ozcan's plans come to fruition. This month's cover article of the journal Lab on a Chip features the latest creation by the Ozcan group, a functioning prototype of a cell phone microscope.
› Verified 3 days ago
Entity Name | Pikeville Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528195864 PECOS PAC ID: 6709790157 Enrollment ID: O20040304001281 |
News Archive
Many cancer patients struggle with the adverse effects of chemotherapy, still the most prescribed cancer treatment. For patients with pancreatic cancer and other aggressive cancers, the forecast is more grim: there is no known effective therapy.
Almost every day brings news of an apparent breakthrough against cancer, infectious diseases, or metabolic conditions like diabetes, but these rarely translate into effective therapies or drugs, and even if they do clinical development usually takes well over a decade.
A common virus that can cause coughing and mild diarrhea appears to have a major redemptive quality: the ability to kill cancer. Harnessing that power, researchers at Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, are conducting a clinical trial to see if the virus can target and kill certain tumor types.
Viragen, Inc. today announced that the Company extended its agreement with the University of Miami and UM/Sylvester Comprehensive Cancer Center to develop a novel form of an immune enhancing drug (IEP 11) that has shown promise in animal studies by inhibiting tumor growth in a broad range of cancers.
Cell phones are accumulating a Swiss Army Knife-esqe assortment of capabilities; substituting as cameras, providing internet access, and soon operating as medical labs if Aydogan Ozcan's plans come to fruition. This month's cover article of the journal Lab on a Chip features the latest creation by the Ozcan group, a functioning prototype of a cell phone microscope.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Matthew Sexton, MD Po Box 432, Pikeville, KY 41502-0432 Ph: (606) 430-3500 | Matthew Sexton, MD 911 Bypass Rd Bldg A, Pikeville, KY 41501-1602 Ph: (606) 430-3500 |
News Archive
Many cancer patients struggle with the adverse effects of chemotherapy, still the most prescribed cancer treatment. For patients with pancreatic cancer and other aggressive cancers, the forecast is more grim: there is no known effective therapy.
Almost every day brings news of an apparent breakthrough against cancer, infectious diseases, or metabolic conditions like diabetes, but these rarely translate into effective therapies or drugs, and even if they do clinical development usually takes well over a decade.
A common virus that can cause coughing and mild diarrhea appears to have a major redemptive quality: the ability to kill cancer. Harnessing that power, researchers at Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, are conducting a clinical trial to see if the virus can target and kill certain tumor types.
Viragen, Inc. today announced that the Company extended its agreement with the University of Miami and UM/Sylvester Comprehensive Cancer Center to develop a novel form of an immune enhancing drug (IEP 11) that has shown promise in animal studies by inhibiting tumor growth in a broad range of cancers.
Cell phones are accumulating a Swiss Army Knife-esqe assortment of capabilities; substituting as cameras, providing internet access, and soon operating as medical labs if Aydogan Ozcan's plans come to fruition. This month's cover article of the journal Lab on a Chip features the latest creation by the Ozcan group, a functioning prototype of a cell phone microscope.
› Verified 3 days ago
Michael Albert Mcclain, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 | |
Dr. William E Duvall, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-3500 Fax: 606-437-1033 | |
Kellie J Stivers, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 | |
Dr. Philip S. Koerper, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 Fax: 606-218-4562 | |
James Chumbley Crouch, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 Fax: 606-437-1033 | |
Dr. John Stuart Puckett, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 |